| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |